These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 28083607)
1. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia. Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607 [TBL] [Abstract][Full Text] [Related]
2. The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy. Rybka J; Butrym A; Wróbel T; Jaźwiec B; Stefanko E; Dobrzyńska O; Poręba R; Kuliczkowski K Leuk Res; 2015 Mar; 39(3):318-22. PubMed ID: 25624047 [TBL] [Abstract][Full Text] [Related]
3. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia. Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression. Barcellini W; Imperiali FG; Zaninoni A; Reda G; Consonni D; Fattizzo B; Lonati S; Nobili L; Zanella A; Cortelezzi A Leuk Lymphoma; 2014 Aug; 55(8):1768-73. PubMed ID: 24144314 [TBL] [Abstract][Full Text] [Related]
5. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma. Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605 [TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation. Rozková D; Novotná L; Pytlík R; Hochová I; Kozák T; Bartůnková J; Spísek R Int J Cancer; 2010 Mar; 126(5):1132-43. PubMed ID: 19685493 [TBL] [Abstract][Full Text] [Related]
8. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia. Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730 [TBL] [Abstract][Full Text] [Related]
9. TLR2 may influence the behavior of the malignant clone in B-CLL. Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M Blood Cells Mol Dis; 2012 Jun; 49(1):32-40. PubMed ID: 22521894 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087 [TBL] [Abstract][Full Text] [Related]
11. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine. Wolska A; Cebula-Obrzut B; Smolewski P; Robak T Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646 [TBL] [Abstract][Full Text] [Related]
12. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection. Shehata MA; Abou El-Enein A; El-Sharnouby GA Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158 [TBL] [Abstract][Full Text] [Related]
14. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412 [TBL] [Abstract][Full Text] [Related]
15. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients. Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia. Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902 [TBL] [Abstract][Full Text] [Related]
17. The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy. Rybka J; Butrym A; Wróbel T; Jaźwiec B; Stefanko E; Dobrzyńska O; Poręba R; Kuliczkowski K Med Oncol; 2014 Dec; 31(12):319. PubMed ID: 25412934 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients. Hancer VS; Diz-Kucukkaya R; Aktan M Med Oncol; 2012 Jun; 29(2):1068-72. PubMed ID: 21264533 [TBL] [Abstract][Full Text] [Related]
20. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]